GLP Watchdog

Does Humana Pay for GLP-1 Medications? (2026)

Humana covers GLP-1 medications only in limited cases; prior authorization is required, and members who are approved typically pay $30-$90 a month.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Where Humana stands[1]
Limited
17,000,000 members · Prior authorization needed[1]
Limited

Where Each Medication Stands[5]

MedicationWhat Humana does
Wegovy (semaglutide)Humana Medicare Advantage Part D plans exclude Wegovy when prescribed for weight loss. Humana applies an automated ICD-10 edit at the point of sale: GLP-1 claims with an obesity diagnosis (E66.x) auto-reject; claims with a diabetes diagnosis (E11.x) or sleep apnea (G47.33) may pay. Wegovy may be covered under Part D for the cardiovascular-risk-reduction indication consistent with CMS March 2024 guidance.
Ozempic (semaglutide)Covered for type 2 diabetes diagnosis on most Humana plans.
Zepbound (tirzepatide)Excluded by Humana Medicare Advantage when prescribed for weight loss (Part D statutory exclusion). May be coverable for the FDA-approved obstructive sleep apnea indication subject to plan criteria.
Mounjaro (tirzepatide)Covered for type 2 diabetes; some plans require step therapy.
Copay when it is covered$30-$90 / month

What a GLP-1 costs a Humana member

At Humana's typical copay of $30-$90 a month, a covered year of a GLP-1 costs $360 to $1,080. That is $3,108 to $3,828 less than a year of Wegovy bought for cash from NovoCare ($4,188), and Zepbound's LillyDirect price of $299 to $449 a month is further above it still.

The cheapest compounded option, Collective at $59/mo ($708 a year), lands inside the Humana range, and 14 sellers charge no more than the $90 top of it, so for a member facing that copay a denial costs less than it sounds.

When Humana covers the drug, a manufacturer savings card can bring a Wegovy or Zepbound fill down to $25, with each maker paying at most $100 a month.

After a Denial from Humana

A Humana denial leaves two routes: an appeal, and paying cash. With a prescription, a brand-name GLP-1 is generally an eligible HSA or FSA medical expense[3]. Compounded semaglutide and tirzepatide from licensed 503A pharmacies[4] cost far less than the brand; the cheapest sellers are listed below.

If a large employer self-funds your Humana plan, ERISA rather than state insurance law applies and the employer decides whether anti-obesity drugs are covered[2]; the Summary Plan Description says which.

Where to go if Humana says no

Sellers that say they work with Humana

Sellers that mention Humana
#SellerCash priceVisit
1Enara HealthPrice not publishedVisit

The 8 cheapest cash-pay compounded GLP-1s

Cheapest cash-pay compounded GLP-1 sellers
#SellerMonthly priceVisit
1Collective
Compounded semaglutide
$59/moVisit
2Boston Medical Group
Compounded semaglutide
$66/moVisit
3OurView Health
Compounded semaglutide
$75/moVisit
4Ivim Health
Compounded semaglutide
$75/moVisit
5Embody
Compounded semaglutide
$79/moVisit
6Lean Meds
Compounded semaglutide
$79/moVisit
7NextMeds
Compounded semaglutide
$79/moVisit
8NuuVim
Compounded semaglutide
$79/moVisit

Every seller and price, side by side: compare all sellers.

Our picks

#ProviderScore
1Trimi HealthVisit
2EmbodyVisit
3CoreAge RxVisit
4bmiMDVisit
5Live VitalVisit

Frequently Asked Questions

Humana Medicare Advantage Part D plans exclude Wegovy when prescribed for weight loss. Humana applies an automated ICD-10 edit at the point of sale: GLP-1 claims with an obesity diagnosis (E66.x) auto-reject; claims with a diabetes diagnosis (E11.x) or sleep apnea (G47.33) may pay. Wegovy may be covered under Part D for the cardiovascular-risk-reduction indication consistent with CMS March 2024 guidance.
Covered for type 2 diabetes diagnosis on most Humana plans.
Excluded by Humana Medicare Advantage when prescribed for weight loss (Part D statutory exclusion). May be coverable for the FDA-approved obstructive sleep apnea indication subject to plan criteria.
Covered for type 2 diabetes; some plans require step therapy.
Members who are approved typically pay $30-$90 a month, which is $360 to $1,080 over a year. A manufacturer savings card can lower that further when the plan covers the drug.
Appeal first: ask Humana for the written denial and the criteria it applied, and have your prescriber answer them in a letter of medical necessity. If the appeal fails, the cheapest cash route is compounded semaglutide or tirzepatide, from Collective at $59/mo or Boston Medical Group at $66/mo. Sellers that say they work with Humana include Enara Health. A compounded drug is not FDA-approved as a finished product.

Glossary

The words sellers use, defined. Tap any term.

How coverage looks nationallyWork out the cash-pay difference
Sources & methodology — as of September 2026
  1. 1.KFF — Employer Health Benefits Annual Survey— Kaiser Family Foundation.
  2. 2.U.S. Department of Labor — ERISA and Employer Health Plans— U.S. Department of Labor, Employee Benefits Security Administration.
  3. 3.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
  4. 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  5. 5.GLP Watchdog insurer coverage index (manually curated formulary data)— GLP Watchdog.